Wedbush Begins Coverage on Sagimet Biosciences (NASDAQ:SGMT)
Wedbush assumed coverage on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a research report report published on Monday morning, MarketBeat.com reports. The firm issued an outperform rating and a $28.00 target price on the stock. SGMT has been the topic of a number of other reports. Canaccord Genuity Group began coverage on shares […]
More Stories
Renting Still Dominates Interstate Moves, but Buyers Lead in Some Metros: NAR
By Mary Prenon While most Americans still follow the long-held pattern of “renting first, buying later” when relocating—especially across state...
Wells Fargo Follows JPMorgan in Cutting Ties With Shareholder Proxy Advisers
By Kevin Stocklin Wells Fargo, America’s fourth largest bank, followed JPMorgan in cutting ties with third-party proxy agents, who advise...
Toronto Man Pleads Guilty to Online Exploitation of More than 100 Girls in US
By Chandra Philip A Toronto man has pleaded guilty to online sexual exploitation of more than 100 girls in the...
More Winter Weather Leads to Heavy Snow, Canceled Flights And, in Florida, Falling Iguanas
By The Associated Press MEMPHIS, Tenn.—A huge swath of the United States from the Gulf Coast into New England was...
House Speaker Says He Has Votes to End Government Shutdown This Week
By Jack Phillips House Speaker Mike Johnson (R-La.) said that he is confident that the House will end the partial...
Democrat Wins Texas Special Election, Eroding GOP’s Slim House Majority
By Jacob Burg Democrat Christian Menefee prevailed in a special election for a Texas U.S. House seat on Jan. 31,...